Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia

News   Feb 20, 2008

 
Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia
 
 
 

RELATED ARTICLES

Artificial Enzyme Can Catalyze Reactions

News

Artificial Biology has taken a step forward as a study shows the catalytic ability of a synthetic enzyme.

READ MORE

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Longevity Protein Could Help Treat Diabetes

News

beta-Klotho, a protein that regulates longevity, could have therapeutic potential for diabetes and obesity.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE